Roushdy has been at the helm of Amoun Pharmaceutical Company since 2012. In 2021, Abu Dhabi’s ADQ acquired Amoun. In April 2024, ADQ’s shareholdings in Acino International, Birgi Mefar Group, and Amoun Pharmaceutical were consolidated under a new Abu Dhabi-headquartered holding company, Arcera. Arcera aims to offer solutions that foster longer and healthier lives, offering 2,000 branded medicines. Roushdy was previously the chairman and CEO of Pfizer Egypt & the Middle East region for 11 years covering 14 countries. He also led the pharmaceutical and health committee in the American Chamber of Commerce in Egypt.